ZERION has developed and patented a technology that enhances the solubility of poorly soluble drugs. The technology is based on mixing the drug compounds with whey protein, a by-product from cheese production. Using the technology, Zerion will enable both the development of novel drug candidates as well as be able to reduce the administered doses of marketed drugs, resulting in higher patient compliance and quality of life.